Allergy Therapeutics Share Discussion Threads

[jimmyloser] 29/12/2022 13:23

The Company announced its unaudited preliminary results on 29 September 2022, and it is not aware of any material change that will be required to be made to the results

[davesailing] 29/12/2022 13:10

20M in cash and an additional17M raised in Oct 2022 - Current market cap now less than 30M GBP! And now they need to raise more cash - no indication of how much more cash is required or when the accounts will be signed off - Maybe a large black hole in the accounts has been uncovered or something more sinister......

[volsung] 29/12/2022 11:56

I don’t think anybody will go near vaccines for the foreseeable lol

[jimmyloser] 29/12/2022 11:50

As red army so rightly pointed out earlier today on here, we do not want a constant stream of shocks. It is such that I really wonder what they will drop on us all to-morrow morning! This is supposed to be boring and steady. Let us have that back.

Shock shut downs not flagged
Needing cash AND SIGNIFICANT AMOUNTS
Lose an FD
Unable to recruit a full time one or worse!
Unaudited results
Lose a credible non-exec.
Two major holders now in control?
Delay results
Need more cash

What on earth are you doing?

[sunshine band] 29/12/2022 11:48

I don't understand. At 30 June they had £20m in cash and in Oct they raised £17m at 20p per share (and debt with warrants exercisable at 30p). Why the short term financing issue?
Presumably the accounts cannot be signed off for technical reasons but it does look like crass incompetence. As did the shut-down of manufacturing which (I suspect) triggered the financing need.
The CEO has been there far too long, as has the Chairman. Salaries and bonuses are out of line with performance.
I love this company and still believe in its prospects. Such a shame it is let down by a board asleep at the wheel. I'm a holder - it's silly to sell at 4p. Maybe in the new year they will come back with a competent executive team (the CFO post has anyway been empty for a while - why?) and a new chairman. The Grass vaccine and the Peanut have huge potential and the current product sales will recover to support a value massively in excess of the current market. OR
The company will fall foul of sharks for its 'short term financing needs' and then all bets are off for us public shareholders. Stay vigilant guys!

[red army] 29/12/2022 11:13

The two major holders should now step up and make the necessary changes as their resources are far more effective than ours. Abbott might even consider a bid but clearly a lot higher. My guess is that most shareholders would accept 15p and the prospects of products in the pipeline will enhance the value in the future. A lot will depend on the VC and when they bought.

[volsung] 29/12/2022 11:12

Biotech is a scam and will leave the naive investor penniless

[genises] 29/12/2022 10:41

With the requirement of substantial additional funds it can only mean one thing 3rd party contracts have been lost.
Obviously the wrong director resigned the CEO should go.

[jpuff] 29/12/2022 10:28

Alas mine are worth so little now that I can't be bothered to sell up now. What a shambles this company has turned out to be with a useless board of directors to boot.

[raleigh43] 29/12/2022 10:16

I sold up all agy today at a chunky loss. Holding suspended shares is often a disaster. Will now watch from the sidelines.

[dds14] 29/12/2022 09:15

I'm always surprised this hasn't been a take over target.

Yes the biotech market sucks at the moment but they have a pipeline of products, a way to make them and a way to sell them which derisks a lot of the problems seen when you pay silly money for clinical programs.

Very surprised to see they appear to have no options.

[red army] 29/12/2022 08:56

This is not the market for scares and takes no prisoners. There have been to may issues badly dealt with recently and a change at the top is required.

[jimmyloser] 29/12/2022 08:42

Get a grip!
Please correct me if I am wrong but if this was terminal, they would have suspended from this morning. Legally, I believe they have to suspend from Wednesday until accounts completed.

Nothing really surprises this morning. Not what we want to read though.

[jpuff] 29/12/2022 08:39

But what price the requirement for funding and what if it isn't forthcoming?

[jimmyloser] 29/12/2022 08:35

I for one think the reaction is nuts!

Okay, all is not right but 4p, come on lads and a handful of shares traded.

[red army] 29/12/2022 08:29

I am going to write to Abbott and suggest that the board gets replaced as it is a comedy of errors and pure incompetence.

[jpuff] 29/12/2022 08:12

Looks like curtains or penny share here we come

[wizzkid211] 29/12/2022 07:04

As previously announced, the Company is actively reviewing all funding options following the voluntary pause in production that has led to the need for significant additional near-term funding. The Company is in active discussions on funding and will update the market in due course.

[wizzkid211] 28/12/2022 07:03

Director Resignation

28 December 2022 Allergy Therapeutics (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today announces that Scott Leinenweber has resigned as a Non-Executive Director of the Group with immediate effect.

[coinbase] 19/12/2022 21:54

Big raise on the cards early in the New Year.

[coinbase] 19/12/2022 21:49

The trend is (sadly) not your friend.

[coinbase] 19/12/2022 21:42

You're MAD.

[jimmyloser] 16/12/2022 21:07

I have been buying this week!

[genises] 16/12/2022 20:36

amazing how a few sells can send the price down so much.
Once they list on the USA market the price will rise on good news.